Strengthening a culture dedicated to patients and equity: A conversation with Vas Narasimhan, CEO of Novartis

This year our industry has been working around the clock to combat the COVID-19 virus, including developing effective therapeutics to treat COVID-19 and vaccines to prevent future infections. Outside of the novel coronavirus, major social issues have been brought to the forefront of public discourse. We understand that systemic racism is as real as any disease and our industry is not immune. We need to stand up to racism and injustice because failing to do so impacts our collective wellbeing. Our industry is committed to learning and leading us forward.

I had the opportunity to connect with Vas Narasimhan, CEO of Novartis, about the industry’s efforts in this space. See below for our conversation

As always, you can stay up-to-date with the work the biopharmaceutical industry is doing to advance equity here.